Chemistry: analytical and immunological testing – Peptide – protein or amino acid
Reexamination Certificate
2006-03-14
2006-03-14
Cole, Moniquet T. (Department: 1743)
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
C436S173000
Reexamination Certificate
active
07011977
ABSTRACT:
Disclosed herein are methods for diagnosing carnitine deficiency in patients and quantifying that deficiency such that carnitine concentrations can be easily and accurately tracked within a given patient over time. Particular embodiments disclosed herein pertain to methods for diagnosing and quantifying the level of carnitine deficiency in patients undergoing dialysis procedures. The diagnosing and quantifying methods allow high throughput and low cost handling while providing high sensitivity and accuracy analysis such that the methods can be used frequently to monitor patient status, diagnose carnitine deficiency, and manage appropriate therapies to treat carnitine deficiency. The preferred embodiments disclosed herein utilize plasma samples taken from patients and dried on filter paper, which samples are then later analyzed using electrospray tandem mass-spectrometry and quantified in a manner that accounts for various complications that can skew free carnitine, acylcarnitine, or total carnitine concentrations.
REFERENCES:
patent: 5252489 (1993-10-01), Macri
patent: 5316917 (1994-05-01), Roe
patent: 6258605 (2001-07-01), Chace
patent: 6335369 (2002-01-01), Cavazza
patent: 6429230 (2002-08-01), Cavazza
patent: 6455321 (2002-09-01), Chace
patent: 6653349 (2003-11-01), Cavazza
patent: 6696492 (2004-02-01), Cavazza et al.
patent: 6696493 (2004-02-01), Cavazza
Savica et al. “Plasma & Muscle Carnitine Levels in Haemodialysis Patients with Morphological-Ulstructural Examination of Muscle Samples,” Nephron 35: 232-236 (1983).
Rodriguez-Segade et al. “Carnitine deficiency in haemodialysed patients,” Clinical Chimica Acta, 159: 249-256 (1986).
Rodriguez-Segade et al. “Camitine concentraions in dialysed and undialysed patients with chronic renal insufficiency,” Ann. Clinical Biochemistry, 23: 671-675 (1986).
Abdenur, J., et al.; Diagnosis of Isovaleric Acidaemia by Tandem Mass Spectrometry: False Positive Result due to Pivaloylcarnitine in a Newborn Screening Programme; J Inher Metab Dis 1998 21:624-630.
Abdenur, J., et al. MCAD Deficiency: Acylcarnitines (AC) by Tandem Mass Spectrometry (MS-MS) are Useful to Monitor Dietary treatment. Adv Exp Med Biol 1999; 466:353-363.
Albers, S, et al. Detection of Neonatal Carnitine Palmitoyltransferase II Deficiency by Expanded Newborn Screening with Tandem Mass Spectrometry, Pediatrics 2001; 107:E103.
Barnes R., et al; Carnitine in Dried Blood Spots: A Method Suitable for Neonatal Screening. Clin Chim Acta 1991; 197:27-33.
Chace, D., et al; Electrospray Tandem Mass Spectrometry for Analysis of Acylcarnitines in Dried Postmortem Blood Specimens Collected at Autopsy from Infants with Unexplained Cause of Death. Clin Chem 2001; 47:1166-1182.
Chace, D., et al; Errors Caused by the Use of D,L-octanolycarnitine for Blood-Spot Calibrators. Clin Chem 2001; 47:758-760.
Clayton P., et al. Screening for Medium Chain Acyl-coA Dehydrogenase Deficiency using Electrospray Ionisation Tandem Mass Spectrometry. Arch Dis Child 1998; 79:109-115.
Gaskell, S., et al Differentation of Isomeric Acylcarnitines using Tandem Mass Spectrometry, Anal Chem 1986; 58:2801-2805.
Gempel, K., et al. Adult Carnitine Palmitoyltransferase II Deficiency: Detection of Characteristic Carnitine Esters in Serum by Tandem Mass Spectrometry. J Inherit Metab Dis 1999; 22:941-942.
Johnson A., et al. The Use of Automated Electrospray Ionization Tandem MS for the Diagnosis of Inborn Errors of Metabolism from Dried Blood Spots. Biochem Soc Trans 1996; 24:932-938.
Johnson, D. Inaccurate Measurement of Free Carnitine by the Electrospray Tandem Mass Spectrometry Screening Methods for Blood Spots. J Inher Metab Dis 1999; 22:201-202.
Kodo, N., et al. Quantitative Assay of Free and Total Carnitine Using Tandem Mass Spectrometry, Clin. Cim Acta 1989; 186:383-390.
Liberato, D., et al. Analysis of Acylcarnitines in Human Metabolic Disease by Thermospray Liquid Chromatography/Mass Spectrometry , In: Burlingame A. A. Castagnoli N, editors. Mass Spectrometry in the Health and Life Sciences. Amsterdam, Netherlands: Elsevier Science Publishers, 1985; 333-348.
Millington D., et al. Application of Fast Atom Bombardment with Tandem Mass Spectrometry and Liquid Chromatogaphy/Mass Spectrometry to the Analysis of Acylcarnitines in Human Urine, Blood and tissue. Anal. Biochem. 1989; 180:331-339.
Millington, D., et al. Tandem Mass Spectrometry: A New Method for Acylcarnitines Profiling with Potential for Neonatal Screening for Inborn Errors of Metabolism. J Inher Metab Dis 1990; 13:321-324.
Millington, D., et al. The Analysis of Diagnostic Markers of Genetic Disorders in Human Blood and Urine using Tandem Mass Spectrometry with Liquid Secondary Ion Mass Spectrometry. Int'l Mass Spectrometry Ion Process 1991; 111:211-228.
Naylor, E. et al. Automated Tandem Mass Spectrometry for Mass Newborn Screening for Disorders in Fatty Acid, Organic Acid and Amino Metabolism. J Child Neurol 1999; 14:S4-S8.
Rashed, M., et al. Diagnosis of Inborn Errors of Metabolism from Blood Spots by Acylcarnitines and Amino Acids Profiling Using Automated Electrospray Tandem Mass Spectrometry. Pediatr Res 1995: 38:324-331.
Stevens R., et l. Assay for Free and Total Carnitine in Human Plasma Using Tandem Mass Spectrometry. Clin Chem 2000; 46:727-729.
Vreken, P., et al. Quantitative Plasma Acylcarnitine Analysis Using Electrospray Tandem Mass Spectrometry for the Diagnosis of Organic Acidaemias and Fatty Acid Oxidation Defects. J Inher Metab Dis 1999 22:302-306.
Wiley, V., et al Newborn Screening with Tandem Mass Spectrometry; 12 Months' Experience in NSW Australia. Acta Paediatr Suppl 1999; 88:48-51.
Yergey, A., et al. Thermospray Liquid Chromatrography/Mass Spectrometry for the Analysis of L-Carnitine and its Short-Chain Acyl Derivates. Anal Biochem 1984; 139:278-283.
Chace Donald H.
Fornasini GianFranco
Cole Moniquet T.
Hogan & Hartson L.L.P.
Sigma-Tau Pharmaceuticals, Inc.
LandOfFree
Quantification of carnitine levels in dialysis patients does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quantification of carnitine levels in dialysis patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quantification of carnitine levels in dialysis patients will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3577011